Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002353191 | SCV002650802 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-04-16 | criteria provided, single submitter | clinical testing | The p.K194N variant (also known as c.582A>C), located in coding exon 5 of the BRIP1 gene, results from an A to C substitution at nucleotide position 582. The lysine at codon 194 is replaced by asparagine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |